News

Nestlé baby formula factory closure puts 500 jobs at risk

By Gwen Ridler

- Last updated on GMT

Nestlé has announced plans to close its Irish baby formula factory by 2026
Nestlé has announced plans to close its Irish baby formula factory by 2026
Food giant Nestlé has announced plans to close its Irish baby formula factory, threatening the jobs of more than 500 people with the risk of redundancy.

Nestlé cited a significant downward trend in demand for infant nutrition products in the Greater China region as the main driver behind the factory closure, thanks to a sharp decline in the birth rate projected in 2023 – 9 million down from 18 million in 2016, according to Statista.

The market, which had previously been reliant on imported infant formula products, is also seeing rapid growth in locally-produced products, according to the manufacturer.

Transferring production

To adapt to these changes, Nestlé planned to transfer the production from Askeaton to two existing factories – Suzhou, Mainland China and Konolfingen, Switzerland – while R&D work would be absorbed into Wyeth and Nestlé Nutrition’s global R&D centre of excellence for infant and maternal products, also in Konolfingen.

Originally acquired from Pfizer nutrition in 2012, Wyeth Nutritionals Ireland Ltd (WNIL) manufactures infant formula products exclusively for export to markets in Greater China and Asia. The factory currently employs 491 people., while the R&D facility employs 51 people.

“These proposals have been carefully considered and are no reflection on the excellent contribution made by our employees in Askeaton over many years,”​ said a Nestlé spokesman.

No buyer found yet

“To date, we have not been able to find a buyer. Therefore, we will commence a meaningful consultation process with our employees on a proposed closure. In parallel, during this consultation we remain open to approaches from a credible buyer. 

“We regret the uncertainty this announcement will cause our colleagues and their families, and we will make sure they are supported fully throughout this process.”

Meanwhile, poultry processor Avara has announced plans to close its Newent factory​ in a move that will impact all colleagues based at the site.

Related products

HRB probiotics in the HMO era

HRB probiotics in the HMO era

Content provided by Morinaga Milk Industry Co., Ltd. | 29-Apr-2024 | White Paper

Discover the science behind human-residential bifidobacteria (HRB) probiotics and their superior benefits for infants.

4 reasons children need MFGM, according to science

4 reasons children need MFGM, according to science

Content provided by Valio | 29-Sep-2023 | White Paper

In this white paper, Dr Anu Turpeinen discusses the ample scientific evidence showing why milk fat globule membrane (MFGM) is essential for children’s...

Introducing a new era in infant nutrition

Introducing a new era in infant nutrition

Content provided by dsm-firmenich | 01-Sep-2023 | Research Study

Omega-3s are critical to infant health and development – but conventional omega-3 ingredients are impacting the planet.

Solutions of Amino Acids-Based Infant Formula

Solutions of Amino Acids-Based Infant Formula

Content provided by INNOBIO Corporation Limited | 22-Jun-2023 | White Paper

Many infants who are born with nutritional defects often need specifically developed infant formulas to maintain their growth and development. Amino acids-based...

Related suppliers

Follow us

Products

View more

Webinars